Esperion Therapeutics has announced a public offering of 30 million shares of common stock, priced at $2.50 per share. This underwritten public offering aims to raise...
Esperion Therapeutics, a biopharmaceutical company based in Ann Arbor, Michigan, has announced its intention to launch a public offering of common stock. The company aims to...
